Cited by 162Health Systems, Economic Evaluations, Quality of LifeStatistical Methods in Clinical TrialsPharmaceutical Economics and Policy

Patient reported outcomes: looking beyond the label claim

Open access
Doward, Lynda C, Gnanasakthy, Ari, Baker, Mary G·2010·Health and Quality of Life Outcomes

Abstract

The use of patient reported outcome scales in clinical trials conducted by the pharmaceutical industry has become more widespread in recent years. The use of such outcomes is particularly common for products developed to treat chronic, disabling conditions where the intention is not to cure but to ameliorate symptoms, facilitate functioning or, ultimately, to improve quality of life. In such cases, patient reported evidence is increasingly viewed as an essential complement to traditional clinical evidence for establishing a product's competitive advantage in the marketplace. In a commercial setting, the value of patient reported outcomes is viewed largely in terms of their potential for securing a labelling claim in the USA or inclusion in the summary of product characteristics in Europe. Although, the publication of the recent US Food and Drug Administration guidance makes it difficult for companies to make claims in the USA beyond symptom improvements, the value of these outcomes goes beyond satisfying requirements for a label claim. The European regulatory authorities, payers both in the US and Europe, clinicians and patients all play a part in determining both the availability and the pricing of medicinal products and all have an interest in patient-reported data that go beyond just symptoms. The purpose of the current paper is to highlight the potential added value of patient reported outcome data currently collected and held by the industry for these groups.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1477-7525-8-89

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Doward, L. C., Gnanasakthy, A., & Baker, M. G.
Affiliations
  • Galen Research (United Kingdom) (GB)
  • Novartis (United States) (US)
  • European Brain Council (BE)
Corresponding author
Doward, Lynda C
Venue
Health and Quality of Life Outcomes
Published
2010
Volume
8
Issue
1
Pages
89
ISSN
1477-7525 (ISSN-L)
OpenAlex
W2108535474
Cited by
162
References
70
Citations by year
2026: 5 · 2025: 14 · 2024: 9 · 2023: 8 · 2022: 11 · 2021: 10 · 2020: 13 · 2019: 10 · 2018: 10 · 2017: 12 · 2016: 15 · 2015: 10 · 2014: 6 · 2013: 14 · 2012: 8
FWCI
21.88
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Health and Quality of Life Outcomes (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
Keywords
patient-reported outcomes, patient-reported outcome measures, pharmaceutical industry, FDA guidance, regulatory approval, quality of life, symptom improvement, drug pricing, payers, clinical trials
MeSH terms
Humans, Quality of Life, Surveys and Questionnaires, Patient Satisfaction, Outcome Assessment, Health Care, Quality Indicators, Health Care, Self Report

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review